
|Articles|September 1, 2001
Supplements and Featured Publications
- Depression and Generalized Anxiety Disorder: Managed Care Considerations
- Volume 7
- Issue 11 Suppl
The Pharmacoeconomics of Venlafaxine in Depression
Author(s)Thomas J. Morrow, MD
Advertisement
Articles in this issue
over 24 years ago
Participating Facultyover 24 years ago
IntroductionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
COVID-19 Vaccination in Pregnant Patients Reduces Hospitalization, Preterm Birth Across Variants
3
FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for Metastatic HER2-Positive Breast Cancer
4
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
5










































